Gossamer Bio Inc (GOSS) concluded trading on 11/15/23 at a closing price of $0.81, with 4.96 million shares of worth about $4.02 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -38.58% during that period and on Wednesday the price saw a gain of about 30.21%. Currently the company’s common shares owned by public are about 225.41M shares, out of which, 188.73M shares are available for trading.
A deeper look into what the analysts at Wall Street are thinking about the price target of this stock provides us with the following: 10 analysts are covering the GOSS stock and their offered price forecasts bring an average price target of $5.34. Over the next 12 months, analysts forecasted that the stock’s price could jump as high as $15.00 and could fall to a lowest price of $0.50. The stock’s current price level is 84.83% above of average price target set by the analysts, while a rise to estimated low would result in loss of -62.0% for the stock. However, touching the estimated high of $15.00 would mean a gain of 94.6% for the stock.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 13 times over the past 12 months. They bought 1,609,772 shares in 9 of the transactions. In 4 selling transactions, insiders dumped 22,970 shares.
Gossamer Bio Inc (NASDAQ: GOSS) started trading at $0.689, above $0.07 from concluding price of the previous day. However, the stock later moved at a day high price of 0.8289, or with a gain of 30.21%. Stock saw a price change of 36.25% in past 5 days and over the past one month there was a price change of 26.91%. Year-to-date (YTD), GOSS shares are showing a performance of -62.64% which decreased to -91.66% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.45 but also hit the highest price of $10.46 during that period. The average intraday trading volume for Gossamer Bio Inc shares is 2.05 million. The stock is currently trading 49.52% above its 20-day simple moving average (SMA20), while that difference is up 15.92% for SMA50 and it goes to -33.91% lower than SMA200.
Gossamer Bio Inc (NASDAQ: GOSS) currently have 225.41M outstanding shares and institutions hold larger chunk of about 68.95% of that.
The stock has a current market capitalization of $182.74M and its 3Y-monthly beta is at 1.38. It has posted earnings per share of -$1.76 in the same period. It has Quick Ratio of 8.07 while making debt-to-equity ratio of 2.06. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for GOSS, volatility over the week remained 21.49% while standing at 13.29% over the month.
Stock’s fiscal year EPS is expected to rise by 54.34% while it is estimated to increase by 34.77% in next year. EPS is likely to grow at an annualized rate of 5.20% for next 5-years, compared to annual growth of -92.43% made by the stock over the past 5-years.
Analysts at 10 brokerage firms have issued recommendations for the Gossamer Bio Inc (GOSS)’s stock and average of those rates the stock at a “Moderate Buy” and assign it a score of 2.00. Out of those 10 Wall Street analysts, 6 recommended a “Buy” rating, while 3 were in favor recommending the stock as a “Hold” and 1 analyst recommended the stock as “Sell”.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by UBS on July 27, 2023 offering a Neutral rating for the stock and assigned a target price range of between $8 and $1.25 to it.
